Zim Laboratories Ltd

NSE: ZIMLAB · BSE: 541400 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.61
Market cap: ₹786.7 Cr
Revenue (annual): ₹374.4 Cr
Net profit (annual): ₹5.84 Cr
P/E (TTM): 212.8×Sector 47.3×
Promoter holding: 30.36%+0.01% QoQ
FII holding: 0.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 6 Merger & Restructuring 5 Annual General Meeting 5 Earnings Call 4 Financial Results 3 Promoter Buying (Off-Market) 2 Board Meeting Date 2 Regulatory Approval 1 Other Announcement 1 Management Change 1 Business Update 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 May 2026 18:03 IST NSE

Regulatory Approval

Zim Laboratories Regulatory Approval

Zim Laboratories received Italian regulatory approval for its Dabigatran Etexilate capsules. This authorization facilitates market entry into Italy and potential expansion across Europe.

Read the filing ↗